Skip to main content
. 2021 Apr 21;28(4):193–200. doi: 10.1136/ejhpharm-2020-002642

Table 1.

Process of development and validation of the CLinical, Economic and Organisational (CLEO) tool

Process Description
Part 1. Development
  • 7 clinical pharmacists from 6 French hospitals (the Expert Group) from SFPC approved the content and structure of the CLEO

Part 2. Internal reliability
  • 30 PIs collected from daily practice

  • Raters: 7 clinical pharmacists from 6 French hospitals (the Expert Group) from SFPC

  • Re-rating: 10 PIs with a wash-out of 1 month

Part 3. External reliability and raters’ opinion
  • 60 PIs were performed from 1 July to 30 September 2019 extracted from the Act-IP website

  • Individual raters: 7 experienced clinical pharmacists (external experts).

  • Users' opinions (7-point Likert scale, 17-item questionnaire)

PI, pharmacist intervention; SFPC, French Society of Clinical Pharmacy.